Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28029303

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2017 Feb 10
First author
Marur S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Feb 10;35(5):479-481. doi: 10.1200/JCO.2016.71.0681.
    note
    Source null
    related pmid
    28029316
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2017 Jun 10;35(17):1969-1970. doi: 10.1200/JCO.2017.72.5085.
    note
    Source null
    related pmid
    28430528
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2017 Jun 10;35(17):1968-1969. doi: 10.1200/JCO.2017.72.2918.
    note
    Source null
    related pmid
    28430529
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2017 Jun 10;35(17):1970-1971. doi: 10.1200/JCO.2017.72.8279.
    note
    Source null
    related pmid
    28430530
    relationship
    Comment in
  5. citation
    Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):1-4. doi: 10.1016/j.ijrobp.2018.04.002.
    note
    Source null
    related pmid
    31200811
    relationship
    Comment in

Authors and identifiers

  1. name
    Marur S
    type
    Author
  2. name
    Li S
    type
    Author
  3. name
    Cmelak AJ
    type
    Author
  4. name
    Gillison ML
    type
    Author
  5. name
    Zhao WJ
    type
    Author
  6. name
    Ferris RL
    type
    Author
  7. name
    Westra WH
    type
    Author
  8. name
    Gilbert J
    type
    Author
  9. name
    Bauman JE
    type
    Author
  10. name
    Wagner LI
    type
    Author
  11. name
    Trevarthen DR
    type
    Author
  12. name
    Balkrishna J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Marur S
    type
    Author
  2. name
    Li S
    type
    Author
  3. name
    Cmelak AJ
    type
    Author
  4. name
    Gillison ML
    type
    Author
  5. name
    Zhao WJ
    type
    Author
  6. name
    Ferris RL
    type
    Author
  7. name
    Westra WH
    type
    Author
  8. name
    Gilbert J
    type
    Author
  9. name
    Bauman JE
    type
    Author
  10. name
    Wagner LI
    type
    Author
  11. name
    Trevarthen DR
    type
    Author
  12. name
    Balkrishna J
    type
    Author
bibliography ids
  1. nci-bib-fb0997a9737aa73061c7ded0
book metadata
content sha256
4fd02d40ae8c98c387a1a2565380bed33742979c707934a0ebec191c42c2b460
document type
citation
dois
  1. 10.1200/JCO.2016.68.3300
electronic publication date
display
2016 Dec 28
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:28029303
immutable id
pubmed:28029303@4fd02d40ae8c98c387a1a2565380bed33742979c707934a0ebec191c42c2b460
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
5
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
490-497
volume
35
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Feb 10;35(5):479-481. doi: 10.1200/JCO.2016.71.0681.
    note
    Source null
    related pmid
    28029316
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2017 Jun 10;35(17):1969-1970. doi: 10.1200/JCO.2017.72.5085.
    note
    Source null
    related pmid
    28430528
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2017 Jun 10;35(17):1968-1969. doi: 10.1200/JCO.2017.72.2918.
    note
    Source null
    related pmid
    28430529
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2017 Jun 10;35(17):1970-1971. doi: 10.1200/JCO.2017.72.8279.
    note
    Source null
    related pmid
    28430530
    relationship
    Comment in
  5. citation
    Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):1-4. doi: 10.1016/j.ijrobp.2018.04.002.
    note
    Source null
    related pmid
    31200811
    relationship
    Comment in
outcomes validated
false
pmid
28029303
provenance
batch id
7a1288ac8bb5f9826304
provider
NCBI PubMed ESummary
record sha256
01d74061f73b19f0455eb8a11f618d69d95020eaede4533840312337d3c1613f
response sha256
0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
retrieved at
2026-09-09T23:47:23.138359+00:00
publication date
display
2017 Feb 10
precision
day
year
2017
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28029303/
title
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.

Preserved source evidence · Not medical advice